Kronos Bio Stock Predictions

Healthcare > Biotechnology

Buy KRON

*Your capital is at risk

$0.88

+0 (+0%)

At Close: Sep 19, 2025

Currently predicting for Mon, 8 Jun 2026

KRON Prediction Chart

KRON Predictions History

Latest community submissions for KRON.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Warren Pro	Jul 14, 2023	$2.02 -1.94%	$2.08	X	97.11%	0
JS Pro	Jul 14, 2023	$2.04 -0.97%	$2.08	X	98.08%	0
PredictionBot.Kathy Pro	Jul 13, 2023	$2.07 -2.91%	$2.06	V	99.61%	5
PredictionBot.Warren Pro	Jul 13, 2023	$2.09 -1.82%	$2.06	V	98.48%	1
JS Pro	Jul 13, 2023	$2.07 -2.82%	$2.06	V	99.51%	5
JS Pro	Feb 22, 2021	$28.53 +2.92%	$27.72	X	97.08%	0
Ben Lawson @BenLawson.214167	Feb 22, 2021	Bullish	$27.72	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KRON with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT KRONOS BIO INC.

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally administered, selective spleen tyrosine kinase inhibitor for acute myeloid leukemia patients. The comp...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	4.09%	May 06
GLBE $31.61	1.65%	May 05
SAP $172.39	7.18%	May 05
FIZZ $34.11	7.04%	May 01
ADBE $243.57	3.23%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by